XIFAXAN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65649-301 -
Package NDC
65649-301-03 -
Application number
NDA021361 -
SPL ID
b2e9bb84-e97e-4e7e-8a23-425418b4374d -
SPL set ID
c5e8e2fd-7087-4b78-9181-cc259c0be2f1 -
UNII
L36O5T016N -
RxCUI
429662 -
RxCUI
539789 -
RxCUI
856664 -
RxCUI
856666
What the source publishes
- Labeler
- Salix Pharmaceuticals, Inc.
- Active ingredients
- rifaximin
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "XIFAXAN",
"splId": "b2e9bb84-e97e-4e7e-8a23-425418b4374d",
"labels": [
{
"setId": "c5e8e2fd-7087-4b78-9181-cc259c0be2f1",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5e8e2fd-7087-4b78-9181-cc259c0be2f1"
}
],
"routes": [
"ORAL"
],
"labeler": "Salix Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (65649-301-03)",
"package_ndc": "65649-301-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20040725"
}
],
"productId": "65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "65649-301",
"deaSchedule": null,
"genericName": "rifaximin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "RIFAXIMIN",
"strength": "200 mg/1"
}
],
"applicationNumber": "NDA021361",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20040725",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175500",
"M0019113"
],
"unii": [
"L36O5T016N"
],
"rxcui": [
"429662",
"539789",
"856664",
"856666"
],
"spl_set_id": [
"c5e8e2fd-7087-4b78-9181-cc259c0be2f1"
],
"pharm_class_cs": [
"Rifamycins [CS]"
],
"pharm_class_epc": [
"Rifamycin Antibacterial [EPC]"
],
"manufacturer_name": [
"Salix Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d"